Locametz Side Effects
Generic name: gallium Ga 68 gozetotide
Note: This document provides detailed information about Locametz.
Applies to gallium Ga 68 gozetotide: intravenous powder for injection Side Effects associated with gallium Ga 68 gozetotide. Some dosage forms listed on this page may not apply specifically to the brand name Locametz.
Applies to gallium Ga 68 gozetotide: intravenous powder for injection.
General adverse events
The most commonly reported adverse reactions were fatigue, nausea, diarrhea, dizziness, constipation, and vomiting.[Ref]
Gastrointestinal
Local
- Uncommon (0.1% to 1%): Injection site reactions (includes injection site warmth and hematoma), chills[Ref]
Other
- Common (1% to 10%): Fatigue[Ref]
References
1. (2022) "Product Information. Locametz (gozetotide)." Advanced Accelerator Applications
2. (2023) "Product Information. Locametz (gozetotide)." Advanced Accelerator Applications (UK & Ireland) Ltd
More about Locametz (gallium Ga 68 gozetotide)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: radiologic conjugating agents
Professional resources
Other brands
Related treatment guides
Further information
Locametz side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.
